Liquidia SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Entry into a material definitive agreement · Termination of a material definitive agreement · Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedLiquidia settles all litigation with United Therapeutics for net $380.7 million in payments, drops PH-ILD indication from YUTREPIA
Other events · Financial statements and exhibits
Other events · Financial statements and exhibits
Results of operations and financial condition · Other events · Financial statements and exhibits